Pulmonary Vein Activity Organization to Determine Atrial Fibrillation Recurrence: Preliminary Data from a Pilot Study

[EN] Ablation of pulmonary veins has emerged as a key procedure for normal rhythm restoration in atrial fibrillation patients. However, up to half of ablated Atrial fibrillation (AF) patients suffer recurrences during the first year. In this article, simultaneous intra-atrial recordings registered at pulmonary veins previous to the ablation procedure were analyzed. Spatial cross-correlation and transfer entropy were computed in order to estimate spatial organization. Results showed that, in patients with arrhythmia recurrence, pulmonary vein electrical activity was less correlated than in patients that maintained sinus rhythm. Moreover, correlation function between dipoles showed higher delays in patients with AF recurrence. Results with transfer entropy were consistent with spatial cross-correlation measurements. These results show that arrhythmia drivers located at the pulmonary veins are associated with a higher organization of the electrical activations after the ablation of these sites.This research was funded by Spanish Ministry of Research and Innovation : PID2019-109547RB-I00. This research was supported by the PID2019-109547RB-I00 National Research Program RETOS from the Spanish Ministry of Research and Innovation and partialy by GVA (PROMETEO/2018/078) & ISCIII (CB16/11/00486). Thanks to Michael Charles Willoughby for English language and scientific editing services.Cervigón, R.; Moreno, J.; Millet Roig, J.; Pérez-Villacastín, J.; Castells, F. (2020). Pulmonary Vein Activity Organization to Determine Atrial Fibrillation Recurrence: Preliminary Data from a Pilot Study. Mathematics. 8(10):1-13. https://doi.org/10.3390/math8101813S113810Andrade, J., Khairy, P., Dobrev, D., & Nattel, S. (2014). The Clinical Profile and Pathophysiology of Atrial Fibrillation. Circulation Research, 114(9), 1453-1468. doi:10.1161/circresaha.114.303211Kim, M. H., Johnston, S. S., Chu, B.-C., Dalal, M. R., & Schulman, K. L. (2011). Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States. Circulation: Cardiovascular Quality and Outcomes, 4(3), 313-320. doi:10.1161/circoutcomes.110.958165Andersson, T., Magnuson, A., Bryngelsson, I.-L., Frøbert, O., Henriksson, K. M., Edvardsson, N., & Poçi, D. (2013). All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study. European Heart Journal, 34(14), 1061-1067. doi:10.1093/eurheartj/ehs469Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., … Murray, C. J. L. (2014). Worldwide Epidemiology of Atrial Fibrillation. Circulation, 129(8), 837-847. doi:10.1161/circulationaha.113.005119Saglietto, A., Matta, M., Gaita, F., Jacobs, V., Bunch, T. J., & Anselmino, M. (2019). Stroke-independent contribution of atrial fibrillation to dementia: a meta-analysis. Open Heart, 6(1), e000984. doi:10.1136/openhrt-2018-000984Wattigney, W. A. (2002). Increased Atrial Fibrillation Mortality: United States, 1980-1998. American Journal of Epidemiology, 155(9), 819-826. doi:10.1093/aje/155.9.819Krijthe, B. P., Kunst, A., Benjamin, E. J., Lip, G. Y. H., Franco, O. H., Hofman, A., … Heeringa, J. (2013). Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. European Heart Journal, 34(35), 2746-2751. doi:10.1093/eurheartj/eht280January, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., … Yancy, C. W. (2019). 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Heart Rhythm, 16(8), e66-e93. doi:10.1016/j.hrthm.2019.01.024Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., … Clémenty, J. (1998). Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins. New England Journal of Medicine, 339(10), 659-666. doi:10.1056/nejm199809033391003Allessie, M. A., Bonke, F. I., & Schopman, F. J. (1976). Circus movement in rabbit atrial muscle as a mechanism of tachycardia. II. The role of nonuniform recovery of excitability in the occurrence of unidirectional block, as studied with multiple microelectrodes. Circulation Research, 39(2), 168-177. doi:10.1161/01.res.39.2.168Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., … Zeppenfeld, K. (2016). 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace, 18(11), 1609-1678. doi:10.1093/europace/euw295Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., … Wilber, D. (2012). 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design. Heart Rhythm, 9(4), 632-696.e21. doi:10.1016/j.hrthm.2011.12.016Ganesan, A. N., Shipp, N. J., Brooks, A. G., Kuklik, P., Lau, D. H., Lim, H. S., … Sanders, P. (2013). Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysis. Journal of the American Heart Association, 2(2). doi:10.1161/jaha.112.004549Pison, L., Tilz, R., Jalife, J., & Haïssaguerre, M. (2016). Pulmonary vein triggers, focal sources, rotors and atrial cardiomyopathy: implications for the choice of the most effective ablation therapy. Journal of Internal Medicine, 279(5), 449-456. doi:10.1111/joim.12490Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., … Vardas, P. (2017). 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS. Revista Española de Cardiología (English Edition), 70(1), 50. doi:10.1016/j.rec.2016.11.033Botteron, G. W., & Smith, J. M. (1995). A technique for measurement of the extent of spatial organization of atrial activation during atrial fibrillation in the intact human heart. IEEE Transactions on Biomedical Engineering, 42(6), 579-586. doi:10.1109/10.387197Cervigón, R., Moreno, J., Millet, J., Pérez-Villacastín, J., & Castells, F. (2010). Propofol Effects on Atrial Fibrillation Wavefront Delays. IEEE Transactions on Biomedical Engineering, 57(8), 1877-1885. doi:10.1109/tbme.2009.2037312Cervigón, R., Castells, F., Gómez-Pulido, J., Pérez-Villacastín, J., & Moreno, J. (2018). Granger Causality and Jensen–Shannon Divergence to Determine Dominant Atrial Area in Atrial Fibrillation. Entropy, 20(1), 57. doi:10.3390/e20010057CASTELLS, F., CERVIGÓN, R., & MILLET, J. (2013). On the Preprocessing of Atrial Electrograms in Atrial Fibrillation: Understanding Botteron’s Approach. Pacing and Clinical Electrophysiology, 37(2), 133-143. doi:10.1111/pace.12288Botteron, G. W., & Smith, J. M. (1996). Quantitative Assessment of the Spatial Organization of Atrial Fibrillation in the Intact Human Heart. Circulation, 93(3), 513-518. doi:10.1161/01.cir.93.3.513Wu, X., & Lu, W. (2019). Four Constructions of Asymptotically Optimal Codebooks via Additive Characters and Multiplicative Characters. Mathematics, 7(12), 1144. doi:10.3390/math7121144Wei, X., Zhang, H., Gong, X., Wei, X., Dang, C., & Zhi, T. (2020). Intrinsic Cross-Correlation Analysis of Hydro-Meteorological Data in the Loess Plateau, China. International Journal of Environmental Research and Public Health, 17(7), 2410. doi:10.3390/ijerph17072410Wang, J., Wang, L., Xi, X., Miran, S. M., & Xue, A. (2020). Estimation and Correlation Analysis of Lower Limb Joint Angles Based on Surface Electromyography. Electronics, 9(4), 556. doi:10.3390/electronics9040556Schreiber, T. (2000). Measuring Information Transfer. Physical Review Letters, 85(2), 461-464. doi:10.1103/physrevlett.85.461Tehrani-Saleh, A., & Adami, C. (2020). Can Transfer Entropy Infer Information Flow in Neuronal Circuits for Cognitive Processing? Entropy, 22(4), 385. doi:10.3390/e22040385Overbey, L. A., & Todd, M. D. (2009). Dynamic system change detection using a modification of the transfer entropy. Journal of Sound and Vibration, 322(1-2), 438-453. doi:10.1016/j.jsv.2008.11.025Calkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., … Sledge, I. (2009). Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation. Circulation: Arrhythmia and Electrophysiology, 2(4), 349-361. doi:10.1161/circep.108.824789Ouyang, F., Bänsch, D., Ernst, S., Schaumann, A., Hachiya, H., Chen, M., … Kuck, K.-H. (2004). Complete Isolation of Left Atrium Surrounding the Pulmonary Veins. Circulation, 110(15), 2090-2096. doi:10.1161/01.cir.0000144459.37455.eeChen, S.-A., Hsieh, M.-H., Tai, C.-T., Tsai, C.-F., Prakash, V. S., Yu, W.-C., … Chang, M.-S. (1999). Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins. Circulation, 100(18), 1879-1886. doi:10.1161/01.cir.100.18.1879SOTOMI, Y., KIKKAWA, T., INOUE, K., TANAKA, K., TOYOSHIMA, Y., OKA, T., … FUJII, K. (2014). Regional Difference of Optimal Contact Force to Prevent Acute Pulmonary Vein Reconnection During Radiofrequency Catheter Ablation for Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 25(9), 941-947. doi:10.1111/jce.12443BALK, E. M., GARLITSKI, A. C., ALSHEIKH-ALI, A. A., TERASAWA, T., CHUNG, M., & IP, S. (2010). Predictors of Atrial Fibrillation Recurrence After Radiofrequency Catheter Ablation: A Systematic Review. Journal of Cardiovascular Electrophysiology, 21(11), 1208-1216. doi:10.1111/j.1540-8167.2010.01798.xAd, N., Holmes, S. D., Patel, J., Je, H. G., & Shuman, D. J. (2017). The Need for Consistent Predictors of Success for Surgical Ablation of Atrial Fibrillation. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 12(6), 421-429. doi:10.1097/imi.0000000000000426Njoku, A., Kannabhiran, M., Arora, R., Reddy, P., Gopinathannair, R., Lakkireddy, D., & Dominic, P. (2017). Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. EP Europace, 20(1), 33-42. doi:10.1093/europace/eux013Ropella, K. M., Sahakian, A. V., Baerman, J. M., & Swiryn, S. (1989). The coherence spectrum. A quantitative discriminator of fibrillatory and nonfibrillatory cardiac rhythms. Circulation, 80(1), 112-119. doi:10.1161/01.cir.80.1.112Cervigón, R., Moreno, J., Sánchez, C., Reilly, R. B., Villacastín, J., Millet, J., & Castells, F. (2008). Atrial fibrillation organization: quantification of propofol effects. Medical & Biological Engineering & Computing, 47(3), 333-341. doi:10.1007/s11517-008-0421-0Cervigón, R., Moreno, J., Reilly, R. B., Pérez-Villacastín, J., & Castells, F. (2012). Quantification of anaesthetic effects on atrial fibrillation rate by partial least-squares. Physiological Measurement, 33(10), 1757-1768. doi:10.1088/0967-3334/33/10/175

Doctor of Philosophy

dissertationFibrillation is defined as turbulent cardiac electrical activity and results in the inability of the myocardium to contract. When fibrillation occurs in the ventricles, it is known as ventricular fibrillation (VF). The consequence of VF is sudden death unless treated immediately. Fibrillation can also occur in the atria and is known as atrial fibrillation (AF). The consequences of atrial fibrillation (AF) are less immediate; however, it leads to increased risk of stroke. Despite the impact of fibrillatory arrhythmias, there are many gaps in our mechanistic knowledge of these arrhythmias. The purpose of this dissertation is to study through several projects how different cardiac substrates help initiate and/or sustain fibrillation. The first project examined several properties of the ventricular conduction system during VF. The conduction system coordinates excitation and consequently coordinates the contraction of the ventricles. Despite the conduction system's unique structure, its role in VF remains unclear. We examined the proximal conduction system and found that it develops a more rapid activation rate than the ventricular myocardium during prolonged VF, and may be driving the arrhythmia. The second and third projects examined the effects of fibrosis on electrical conduction to initiate and/or sustain AF. Despite fibrosis being associated with AF, it is still unknown whether it is a byproduct of an underlying heart disease and does not in itself promote AF, or if it affects the organization of conduction during fibrillation to promote AF. In the second project we studied the effect of fibrosis on conduction following different types of triggers. We found that fibrosis causes transverse conduction slowing following premature stimulation, which makes AF more likely to initiate. As AF persists, single episodes of AF last longer before the patient transitions into normal sinus rhythm, and in some cases AF can become permanent. The third project examined why some patients may never transition from AF to normal sinus rhythm. Specifically, this project found that regions of dense fibrosis anchor high-frequency activation that may be driving the arrhythmia. These studies showed that fibrosis causes conduction changes that make AF more likely to initiate and to be sustained

New Paradigm of Defibrillation: Towards Painless Therapy

Sudden cardiac death: SCD) causes approximately 300,000 - 400,000 deaths a year in the United States. It usually starts as ventricular tachycardia: VT) and then degenerates into ventricular fibrillation: VF). Implantable cardioverter defibrillator: ICD) therapy is the only reliable treatment of VT/VF and has been shown to effectively reduce mortality by many clinical trials. However, high-voltage ICD shocks could result in myocardial dysfunction and damage. The majority of patients receiving ICD therapy have a history of coronary disease; their hearts develop myocardium infarction, which could provide a substrate for reentrant tachy-arrhythmias. Other than lethal ventricular tachycardia, atrial fibrillation: AF) became the most common arrhythmia by affecting 2.2 to 5.6 millions of Americans. The complications of AF include an increased rate of mortality, heart failure, stroke, etc. In this dissertation, we explore mechanisms of sustained ventricular and atrial tachyarrhythmias and the mechanisms of defibrillation using the conventional high-voltage single shock. Through the use of novel fluorescent optical mapping techniques and several animal models of ventricular and atrial arrhythmias, we develop and validate several novel low-voltage defibrillation therapies for atrial and ventricular arrhythmias. Several important previous studies on mechanisms of arrhythmia maintenance and termination using mathematical and experimental models are overviewed in Chapter 2. A study on multiple monophasic shocks improving electrotherapy of ventricular tachycardia in rabbit model of chronic infarction is presented in Chapter 3. Ventricular arrhythmias and low-voltage defibrillation therapy are studied in a more clinically-relevent in vivo canine model of healing myocardial infarction in Chapter 4. Finally, Chapter 5 presents a novel multi-stage low-energy defibrillation therapy for atrial fibrillation in in vivo canine hearts

Acoustic Radiation Force Impulse Imaging of Radiofrequency Ablation Lesions for Cardiac Ablation Procedures

<p>This dissertation investigates the use of intraprocedure acoustic radiation force impulse (ARFI) imaging for visualization of radiofrequency ablation (RFA) lesions during cardiac transcatheter ablation (TCA) procedures. Tens of thousands of TCA procedures are performed annually to treat atrial fibrillation (AF) and other cardiac arrhythmias. Despite the use of sophisticated electroanatomical mapping (EAM) techniques to validate the modification of the electrical substrate, post-procedure arrhythmia recurrence is common due to incomplete lesion delivery and electrical conduction through lesion line discontinuities. The clinical demand for an imaging modality that can visually confirm the presence and completeness of RFA lesion lines motivated this research.</p><p>ARFI imaging is an ultrasound-based technique that transmits radiation force impulses to locally displace tissue and uses the tissue deformation response to generate images of relative tissue stiffness. RF-induced heating causes irreversible tissue necrosis and contractile protein denaturation that increases the stiffness of the ablated region. Preliminary in vitro and in vivo feasibility studies determined RF ablated myocardium appears stiffer in ARFI images.</p><p>This thesis describes results for ARFI imaging of RFA lesions for three research milestones: 1) an in vivo experimental verification model, 2) a clinically translative animal study, and 3) a preliminary clinical feasibility trial in human patients. In all studies, 2-D ARFI images were acquired in normal sinus rhythm and during diastole to maximize the stiffness contrast between the ablated and unablated myocardium and to minimize the bulk cardiac motion during the acquisition time.</p><p>The first in vivo experiment confirmed there was a significant decrease in the measured ARFI-induced displacement at ablation sites during and after focal RFA; the displacements in the lesion border zone and the detected lesion area stabilized over the first several minutes post-ablation. The implications of these results for ARFI imaging methods and the clinical relevance of the findings are discussed.</p><p>The second and third research chapters of this thesis describe the system integration and implementation of a multi-modality intracardiac ARFI imaging-EAM system for intraprocedure lesion evaluation. EAM was used to guide the 2-D ARFI imaging plane to targeted ablation sites in the canine right atrium (RA); the presence of EAM lesions markers and conduction disturbances in the local activation time (LAT) maps were used to find the sensitivity and specificity of predicting the presence of RFA lesion with ARFI imaging. The contrast and contrast-to-noise ratio between RFA lesion and unablated myocardium were calculated for ARFI and conventional ICE images. The opportunities and potential developments for clinical translation are discussed. </p><p>The last research chapter in this thesis describes a feasibility study of intracardiac ARFI imaging of RFA lesions in clinical patients. ARFI images of clinically relevant ablation sites were acquired, and this pilot study determined ARFI-induced displacements in human myocardium decreased at targeted ablation sites after RF-delivery. The challenges and successes of this pilot study are discussed.</p><p>This work provides evidence that intraprocedure ARFI imaging is a promising technology for the visualization of RFA lesions during cardiac TCA procedures. The clinical significance of this research is discussed, as well as challenges and considerations for future iterations of this technology aiming for clinical translation.</p>Dissertatio